Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results

Yankeelov, Thomas E.; Lepage, Martin; Chakravarthy, A. Bapsi; Broome, Elizabeth E.; Niermann, Kenneth J.; Kelley, Mark C.; Meszoely, Ingrid M.; Mayer, Ingrid A.; Herman, Cheryl R.; McManus, Kevin; Price, Ronald R.; Gore, John C.

doi:10.1016/j.mri.2006.09.006

Cited by 284 publications

(283 citation statements)

References 40 publications

Supporting

Mentioning

266

Contrasting

Unclassified

Order By: Relevance

“…Recent publications describe an increase in specificity with the use of diffusion-weighted imaging (DWI) [6 -8]. Moreover, DWI can be useful for the detection [9], assessment [10 -14] or treatment response monitoring [15,16] of breast cancer. However, when using DWI, the applied pulse sequences, b-values and approach (before or after contrast administration, selected slices or complete volumes) differ in most publications [17].…”

mentioning

confidence: 99%

Diffusion-Weighted MR Imaging of Benign and Malignant Breast Lesions Before and After Contrast Enhancement

Janka

Hammon

Geppert

et al. 2013

Fortschr Röntgenstr

View full text Add to dashboard Cite

Mamma 130Janka R et al. 50, 400 und 800) wurde vor und nach KM-Gabe gemessen und die entsprechenden ADC-Werte der Läsionen verglichen. Vor der Berechnung der ADC-Werte wurden die Läsionen bezüglich ihrer konstanten Lokalisation in den diffusionsgewichteten Sequenzen analysiert. Ergebnisse: Die mittlere Größe der Läsionen war 1,5 ± 0,8 cm. Auf der Basis der b50-und b400-Messung betrug der durchschnittliche ADC-Wert der benignen Läsionen 1,89 ± 0,30 × 10 -3 mm 2 /s vor und 1,85 ± 0,28 × 10 -3 mm 2 /s nach KM-Gabe. Die entsprechenden Werte für zwei muzinöse Karzinome betrugen 1,88 × 10 -3 mm 2 /s und 1,81 × 10 3 mm 2 /s und für die übrigen malignen Läsionen 1,00 ± 0,18 × 10 -3 mm 2 /s und 0,88 ± 0,21 × 10 -3 mm 2 . Auf der Basis der b50-, b400-und b800-Messung betrug der durchschnittliche ADC-Wert der benignen Läsionen 1,99 ± 0,37 × 10 -3 mm 2 /s vor und 1,97 ± 0,30 × 10 -3 mm 2 /s nach KM-Gabe. Der mittlere ADC-Wert der malignen Läsionen betrug 0,90 ± 0,14 × 10 -3 mm 2 /s vor und 0,80 ± 0,14 × 10 -3 mm 2 /s nach KM-Gabe. Während der ADC-Wert der gutartigen Läsionen durch das Kontrastmittel nicht signifikant beinflusst wurde, war er bei den malignen Läsionen nach Kontrastmittelgabe signifikant niedriger. Abstract !Purpose: Many publications describe the use of diffusion-weighted imaging (DWI) in breast MRI. This article addresses the question of when to apply the DWI sequence in the course of the scan protocol. The effect of T1-shortening contrast media (CM) on the ADC values of breast lesions is investigated. Materials and Methods: Data were acquired on a 1.5 T scanner. 60 patients with 79 lesions (20 benign, 59 malignant) were included. The DWI sequence (4 mm slice thickness, b-values: 50, 400, 800) was applied before and after CM administration. Before calculating the ADC map, the b50, b400 and b800 series were analyzed concerning lesion displacement. ADC values before and after CM application were compared.

show abstract

mentioning

confidence: 99%

Diffusion-Weighted MR Imaging of Benign and Malignant Breast Lesions Before and After Contrast Enhancement

Janka

Hammon

Geppert

et al. 2013

Fortschr Röntgenstr

View full text Add to dashboard Cite

show abstract

“…Guidelines for the use of DW-MRI as a cancer biomarker have been suggested, and emphasize the need for both validation and assessment of reliability of this method in oncologic imaging (11). The unique possibility of including several MR methods in one examination has made multiparametric studies of several tumor features possible; however, only a few studies have exploited this with respect to treatment response in breast cancer (12,13).…”

mentioning

confidence: 99%

Diffusion‐weighted and dynamic contrast‐enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients

Jensen¹,

Garzón²,

Heldahl³

et al. 2011

Magnetic Resonance Imaging

View full text Add to dashboard Cite

Purpose: To use dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) MRI at 3 Tesla (T) for early evaluation of treatment effects in breast cancer patients undergoing neoadjuvant chemotherapy (NAC), and assess the reliability of DW-MRI.Materials and Methods: DW-and DCE-MRI acquisitions of 15 breast cancer patients were performed before and after one cycle of NAC. MRI tumor diameter and volume, apparent diffusion coefficient (ADC) and kinetic parameters (K trans , v e ) were derived. The reliability of ADC before NAC was assessed. Changes in MRI parameters after NAC were analyzed, and logistic regression analysis was used to find the best predictors for pathologic response. Results:The reliability for ADC values was high, with intraclass correlation coefficient of 0.84 (P ¼ 0.001). After one cycle of NAC, MRI tumor diameter (8%, P ¼ 0.005) and tumor volume (30%, P ¼ 0.008) was reduced for all patients, while ADC mean values increased (0.12 mm 2 /s, P ¼ 0.008). The best predictor for treatment response was a change in MRI tumor diameter with mean error rate of 0.167 (13% for responders, 5% for nonresponders, P ¼ 0.291).Conclusion: Changes in MRI derived tumor diameter and ADC after only one cycle of NAC could provide a valuable tool for early evaluation of treatment effects in breast cancer patients.

show abstract

“…Malignant tumors have lower ADC values than normal tissue or benign lesions (19) due to higher cellularity, disorganized tissue, and increased extracellular space tortuosity (20). Successful cancer therapies have been associated with an early increase in ADC in animal xenograft models and human tumors (21)(22)(23)(24)(25). DW-MRI may also reveal differences between necrotic and viable tissues.…”

mentioning

confidence: 99%

In vivo MRI and histopathological assessment of tumor microenvironment in luminal‐like and basal‐like breast cancer xenografts

Huuse

Moestue

Lindholm

et al. 2011

Magnetic Resonance Imaging

View full text Add to dashboard Cite

Purpose: To explore tumor pathophysiology with special attention to the microenvironment in two molecular subtypes of human breast cancer using in vivo magnetic resonance imaging (MRI) and histopathology. The impact of tumor growth, size, and the influence of estradiol were also investigated. Materials and Methods:Two orthotopic and directly transplanted human breast cancer models representing luminal-like and basal-like molecular subtypes were characterized by dynamic contrast-enhanced MRI and diffusion-weighted MRI. Ex vivo measurements of vascularization, hypoxia, mitoses, and the level of VEGF activations were associated with the calculated in vivo MRI parameters of the tumors. Results:The vascular permeability and perfusion (K trans ) was significantly higher in basal-like compared to luminal-like tumors. These findings were confirmed by a 4-fold higher proliferating microvessel density (pMVD) in basal-like tumors, reflecting the difference in aggressiveness between the subtypes. No effect of tumor growth was observed during 6 days of growth in any of the models; however, large tumors had lower K trans , higher extracellular extravascular volume fraction (v e ), and more hypoxia than medium-sized tumors. Estradiol withdrawal induced increased K trans , v e , and tumor water diffusion (ADC) in luminal-like tumors, corresponding to increased VEGFR2 activation, which is likely to cause increased tumor vessel permeability.Conclusion: These novel data confirm the potential of functional MRI methods to map histopathologically proven changes in breast tumor vasculature and microenvironment in vivo.

show abstract

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results

Cited by 284 publications

References 40 publications

Diffusion-Weighted MR Imaging of Benign and Malignant Breast Lesions Before and After Contrast Enhancement

Diffusion-Weighted MR Imaging of Benign and Malignant Breast Lesions Before and After Contrast Enhancement

Diffusion‐weighted and dynamic contrast‐enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients

In vivo MRI and histopathological assessment of tumor microenvironment in luminal‐like and basal‐like breast cancer xenografts

Contact Info

Product

Resources

About